Aquestive Therapeutics AQST
NASDAQ AQST
$4.43 -0.16 (-3.49%)
At close: Aug 20, 2026 · 1:57 PM UTC

Aquestive Therapeutics (AQST) Current Leases (2020 - 2026)

Aquestive Therapeutics (AQST) posted quarterly Current Leases of $662000.0 for Q1 2026, up 22.59% year-over-year from $540000.0 in Q1 2025, and up 4.91% quarter-over-quarter from $631000.0 in Q4 2025.

Aquestive Therapeutics (AQST) Current Leases (2020 - 2026) Analysis & Trends

Aquestive Therapeutics' Current Leases history runs 7 years deep, the most recent figure standing at $662000.0 for Q1 2026.

  • In Q1 2026, Current Leases rose 22.59% year-over-year to $662000.0; the TTM figure through Mar 2026 stood at $662000.0 (up 22.59% YoY), while the FY2025 annual figure was $631000.0, up 23.73% from the prior year.
  • Current Leases for Q1 2026 stood at $662000.0, up from $631000.0 in the prior quarter.
  • The five-year high for Current Leases was $926000.0 in Q1 2022, with the low at $255000.0 in Q4 2022.
  • The 5-year median for Current Leases is $510000.0 (2024), against an average of $543352.9.
  • The sharpest annual moves came in 2022 and 2023: Current Leases slumped 71.64% in 2022, then jumped 52.94% in 2023.
  • Aquestive Therapeutics' Current Leases stood at $255000.0 in 2022, then soared by 52.94% to $390000.0 in 2023, then soared by 30.77% to $510000.0 in 2024, then gained by 23.73% to $631000.0 in 2025, then advanced by 4.91% to $662000.0 in 2026.
  • Business Quant data shows AQST's Current Leases at $662000.0 in Q1 2026, $631000.0 in Q4 2025, and $601000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 42.98 Bn 39.32 Bn 2.15 Bn -
3 Zoetis 31.53 Bn 29.86 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn -
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn -
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn -
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn - -
10 Aquestive Therapeutics 554.85 Mn 554.85 Mn 9.80 Mn 820,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 820,000.00
Mar 31, 2026 662,000.00
Dec 31, 2025 631,000.00
Sep 30, 2025 601,000.00
Jun 30, 2025 570,000.00
Mar 31, 2025 540,000.00
Dec 31, 2024 510,000.00
Sep 30, 2024 482,000.00
Jun 30, 2024 455,000.00
Mar 31, 2024 414,000.00
Dec 31, 2023 390,000.00
Sep 30, 2023 367,000.00
Jun 30, 2023 347,000.00
Mar 31, 2023 328,000.00
Dec 31, 2022 255,000.00
Sep 30, 2022 846,000.00
Jun 30, 2022 913,000.00
Mar 31, 2022 926,000.00
Dec 31, 2021 899,000.00
Sep 30, 2021 860,000.00